1. Home
  2. TARA vs DPRO Comparison

TARA vs DPRO Comparison

Compare TARA & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$5.23

Market Cap

268.5M

Sector

Health Care

ML Signal

HOLD

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$5.93

Market Cap

230.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARA
DPRO
Founded
N/A
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
268.5M
230.7M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
TARA
DPRO
Price
$5.23
$5.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$23.60
$15.00
AVG Volume (30 Days)
581.6K
1.8M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
38.25
N/A
EPS
N/A
N/A
Revenue
$2,948,000.00
N/A
Revenue This Year
N/A
$158.69
Revenue Next Year
N/A
$131.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.77
$1.63
52 Week High
$7.82
$14.37

Technical Indicators

Market Signals
Indicator
TARA
DPRO
Relative Strength Index (RSI) 47.57 52.10
Support Level $4.92 $4.36
Resistance Level $5.44 $7.07
Average True Range (ATR) 0.27 0.40
MACD 0.05 0.16
Stochastic Oscillator 60.14 94.82

Price Performance

Historical Comparison
TARA
DPRO

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: